Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Eric P. Borrelli"'
Autor:
Aisling R. Caffrey, Eric P. Borrelli
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 11 (2020)
A “one-size-fits-all” approach has been the standard for drug dosing, in particular for agents with a wide therapeutic index. The scientific principles of drug titration, most commonly used for medications with a narrow therapeutic index, are to
Externí odkaz:
https://doaj.org/article/8e60d009e96147c8b40a1d2a149591b9
Publikováno v:
Substance Use & Misuse. 58:1038-1045
Autor:
Eric P. Borrelli, PhD, PharmD, MBA, Jeffrey Bratberg, PharmD, FAPhA, Mary L. Greaney, PhD, MPH, Stephen J. Kogut, PhD, MBA, RPh
Publikováno v:
Journal of Opioid Management. 19:257-271
Objective: To assess prescribing of tramadol among patients with contraindications and higher risks of adverse events in a large population of commercially insured and Medicare Advantage members. Design: We performed a cross-sectional analysis evalua
Publikováno v:
AIDS Care. :1-12
Chronic complications are a significant concern for people living with HIV/AIDS (PLWHA) infection. HIV-associated neurocognitive disorders (HAND) are prevalent in PLWHA. Yet, the efficacy of medications that penetrate the central nervous system (CNS)
Publikováno v:
Journal of the American Pharmacists Association.
Autor:
Eric P, Borrelli, R Scott, Leslie
Publikováno v:
The American journal of managed care. 28(10)
Pharmacoeconomic analyses are an important and useful guide for understanding a pharmacotherapeutic intervention's financial impact for relevant stakeholders. One type of pharmacoeconomic analysis that assesses a pharmacotherapeutic intervention's sh
Autor:
Eric P Borrelli, Conor G. McGladrigan
Publikováno v:
Journal of Pharmacy Practice. 35:580-586
Introduction: Oral oncolytics are becoming a mainstay in oncology, representing first-line therapies for numerous different malignancies. In addition, the cost of oncology drugs has increased dramatically in recent years. Given the increasing number
Publikováno v:
Journal of managed carespecialty pharmacy. 28(1)
Publikováno v:
Epilepsia. 59:2318-2324
Objective Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare and potentially fatal adverse skin reactions that are most commonly triggered by certain medications. One class of medications that has been highly associated with